探索认知刺激作为一种治疗方法,用于在医院环境中预防狂妄症:叙述性审查
Emman Fatima1, Ian Hill1, Noah Dover2
1School of Medicine, Creighton University, Omaha, NE 68178, USA.
Behavioral sciences (Basel, Switzerland)
|February 26, 2025
概括
痴呆症是重症患者常见的疾病,可以通过非药物治疗方法来治疗. 数字认知刺激在预防和治疗妄方面表现有前途,解决了医院的可扩展性问题.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 临界护理医学 临界护理医学
背景情况:
- 妄想症是重症患者中普遍存在的一种神经精神疾病,影响认知功能,导致显著的医疗保健费用.
- 症状包括注意力缺陷,记忆障碍,感知障碍和行为变化.
- 非药物干预可以减少妄想的发生率和持续时间,但在医院环境中面临可扩展性挑战.
研究的目的:
- 探索基于数字技术的传统和新型认知刺激技术,以预防和管理妄想.
- 解决急性医院环境中数字干预的有限证据.
主要方法:
- 这项研究是叙事文献综述.
- 它检查了关于痴呆症认知刺激的现有研究.
- 重点放在传统和数字方法上.
主要成果:
- 非药物干预是有效的,但受到资源限制和交付复杂性的限制.
- 数字认知刺激为克服这些障碍提供了一个潜在的解决方案.
- 目前支持数字干预妄症的证据不足.
结论:
- 数字认知刺激提供了一种可扩展的方法,用于医院的妄想管理.
- 需要进一步的研究来确定数字干预措施的有效性.
- 整合技术可能会改善患者的治疗结果,并减少与妄想相关的医疗负担.
相关概念视频
Cognitive Development During Adulthood
44
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
44
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
94
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
94
Alzheimer's Disease: Treatment
147
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
147
Cognitive Therapy
77
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
77
Dementia
88
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
88


